Astragalosides attenuate learning and memory impairment in rats following ischemia‑reperfusion injury

  • Authors:
    • Yang‑Yang Wu
    • Wang‑Yang Wu
    • Hui‑Ling Gong
    • Wei‑Zu Li
    • Yan‑Yan Yin
  • View Affiliations

  • Published online on: February 19, 2014     https://doi.org/10.3892/mmr.2014.1969
  • Pages: 1319-1324
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Astragalosides (ASTs) have been traditionally used in the treatment of various cardiovascular and cerebrovascular diseases. The aim of the present study was to investigate the neuroprotective effects of AST on learning and memory following focal cerebral ischemia/reperfusion in a rat model. A Morris water maze was used to measure the effect of AST on learning and memory impairments. A histological examination and Hoechst 33258 staining was used to observe the neuronal changes and apoptosis in the hippocampus. The activity of phospho-extracellular signal‑regulated kinases (p‑ERK), p‑c-Jun N-terminal kinases (JNK) and p‑Akt was measured by western blotting. The data revealed that AST improved the rats learning and memory abilities, attenuated neuronal cells apoptosis, increased the expression of p‑ERK and p‑Akt, and decreased the expression of p‑JNK. These findings indicated that AST has protective effects that may be correlated with the inhibition of neuronal cell apoptosis and the regulation of p‑ERK, p‑Akt and p‑JNK expression.

Introduction

Ischemic brain injury is a common cause of permanent disability and is associated with dementia and cognitive decline in the elderly (1). Certain surgical procedures that involve the reduction or interruption of the blood supply to the brain and events such as strokes, are often accompanied by memory loss that persists for several months during recovery. These changes are believed to be associated with focal cerebral ischemia. The middle cerebral artery occlusion model (MCAO) that was originally developed in rats is considered to be a reliable and reproducible model. The model induces deficits in cognitive function in the rats, which appear to remain fairly stable (2,3).

Neurotrophic factors are known to be critical in neurite outgrowth and cell survival. Nerve growth factor (NGF) and brain-derived neutrophic factor (BDNF) may bind to acceptors, stimulate the downstream signaling pathways and protect rat hippocampal neurons against ischemic cell damage (4). Mitogen-activated protein kinase (MAPK) family members, including extracellular signal-regulated kinases (ERK)1/2, p38 MAPK and c-Jun N-terminal kinase (JNK), respond to various extracellular stimuli, thereby transmitting extracellular signals into the nucleus. The JNK signaling pathway is a potential cascade mediating neuronal apoptosis triggered by focal ischemia (5). While, the MEK/ERK pathway is important in cell growth and differentiation following ischemia, activation of the Akt kinase pathway by growth factors also has neuroprotective effects (6).

Astragalus is a traditional Chinese medicine, also known as legumes Mongolia astragalus or the dried root of Astragalus membranaceus (Fisch.) Bge. Astragalosides (ASTs) are the main component of Astragalus and function as antioxidants, in immune regulation and to promote intelligence. ASTs have been commonly used in the prevention and treatment of cardiovascular and cerebrovascular diseases, aging, immune function disorders and other diseases. Our previous studies revealed that ASTs have protective effects against ischemic damage (7,8) and improve behavioral disorders, including problems with spatial learning and memory in AD rats (9); therefore, we hypothesize that AST may improve the learning and memory abilities of rats following ischemia reperfusion (I/R) injury. On the basis of the association between cognitive decline and AST, the current study was performed to observe whether AST regulates the behavioral disorder in rats following ischemia, and its possible mechanism.

Materials and methods

Reagents

AST brown powder (content, >95% AST) was provided by the Institute of Anhui Hengxing Medicine (Hefei, China). Ginaton (Gin) was provided by Willmar Schwabe Pharmaceuticals (Karlsruhe, Germany). Hochest 33258 was provided by Sigma (St. Louis, MO, USA). ERK, phospho (p)-ERK, JNK, p-JNK, Akt and p-Akt monoclonal antibodies were obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA).

Animals

Sprague-Dawley rats (weight, 250–325 g) were supplied by The Experimental Animal Center of Anhui Medical University (Hefei, China). Animals were housed four per cage, allowed access to water and food ad libitum and maintained in a constant temperature of 22±2°C, with a humidity of 50±10% under a 12 h light/dark cycle. Animal treatment and maintenance was conducted in accordance with the guidelines for the humane treatment of animals set by the association of Laboratory Animal Sciences and The Center for Laboratory Animal Sciences at Anhui Medical University.

Rat I/R model and treatment

The MCAO surgery was conducted according to previously described methods (10). The rats were anesthetized by 10% chloral hydrate (300 mg/kg, intraperitonealy) and placed in dorsal recumbency. A longitudinal incision of 1.5 cm in length was made in the midline of the ventral cervical skin. The right common carotid artery, internal carotid artery (ICA) and external carotid artery (ECA) were exposed and carefully isolated. A nylon monofilament (40 mm in length and 0.24 mm in diameter), its tip rounded by flame-heating, was inserted from the lumen of the ECA to that of the right ICA to occlude the origin of the right middle cerebral artery (MCA). The right MCA was occluded for 120 min, following which, the cerebral blood flow was restored by withdrawal of the nylon thread.

As a means of assessing the adequacy of the occlusion, a neurological score was assigned to each animal 5 min prior to removing the occlusion and at 22 h after reperfusion: 0, no deficit; 1, forelimb weakness; 2, circling to the affected side, 3, partial paralysis on the affected side; and 4, no spontaneous motor activity. Following 120 min of occlusion, all the animals were randomly assigned according to the neurological function deficit score (11) to one of the following groups: I/R, AST (20, 40 and 80 mg/kg) or Gin (40 mg/kg). The rats were administered treatment by gavage at 0, 8 and 24 h reperfusion, then once a day for 7 days. Sham-control animals were prepared in the same way, with the exception of the insertion of a nylon surgical thread into the right ICA. The animal body temperature was maintained at 37±1°C during and following the surgery. The animals were sacrificed by decapitation following a Morris water maze (MWM) test at reperfusion day 7, and the brain was used for immunohistochemistry.

Another batch of rats was randomly divided into the following five groups: Sham, I/R, Gin (40 mg/kg) and AST (40 and 80 mg/kg). These rats were administrated treatment by gavage once a day for 7 days. After the last intragastric administration, the rats were underwent MCAO for 120 min, then the thread was withdrawn and the blood flow for was restored for 22 h, before the rats were sacrificed. A neurological score was assigned to each animal 5 min prior to removing the occlusion and at 22 h post-reperfusion. At 22 h after reperfusion, the rats were sacrificed and the brains were dissected, frozen in powdered dry ice and stored at −80°C until further use for western-blotting.

MWM test

An MWM was used to test spatial learning and memory, and was performed on days 4, 5, 6 and 7 post-ischemia. The maze consisted of a black circular pool 2.14 m in diameter and 80 cm in height, filled with water at 21–22°C to a height of 50 cm. A black circular platform that was 9 cm in diameter was placed 2.0 cm below the water line in the center of one quadrant and remained in the same position. Several, constant, large visual cues surrounded the tank at a height of 120–150 cm to facilitate orientation. The rat was placed in the water facing the wall at one of four random start locations (north, south, east and west, locating at equal distances from each other on the pool rim). Each rat was allowed to locate the submerged platform within 90 sec and rest on it for 20 sec. If the rat failed to locate the hidden platform within 90 sec, it was placed on it for 20 sec. The procedure was repeated for all the four starting locations. The latency to reach the platform and the swimming speed were recorded, each representing the average of four trials. The escape latency, i.e. the time to reach the platform, and the length of the path the animal swam to find the platform were used to assess the acquisition of the water-maze task. The shorter the latency to locate the platform, the better the rats memory for its location was considered to be.

Histological examination

For the histological examination, the rats were perfused transcardially with normal saline, followed by fixation with 4% paraformaldehyde. The brains were removed and stored in the same paraformaldehyde solution. Serial paraffin sections were cut coronally on a Leica microtome (Mannheim, Germany). The sections were stained with hematoxylin and eosin (H&E) and examined under a light microscope (Olympus, Tokyo, Japan).

Hoeschst 33258 staining

For nuclear staining, the paraffin sections were deparaffinized with xylene (Beyotime, Shanghai, China) twice for 15 min at 37°C, washed with phosphate-buffered saline (PBS), mounted onto slides using antifade mounting medium (Beyotime,) and then examined by fluorescence microscopy (Olympus). Morphologically, cells undergoing apoptosis should appear smaller than normal, with chromatin that appears condensed and deeply stained. Cellular fragmentation into apoptotic bodies also occurs.

Western blotting

The rats were sacrificed by decapitation at a specified time under anesthesia. The infarcted brains were separated, frozen quickly in liquid nitrogen and stored at −80°C. The tissues were homogenized in ice-cold homogenization buffer (HB; Beyotime). Following the protein concentration measurement using the Lowry method, with bovine serum used as a standard, each sample was diluted to equal protein concentrations with HB. Next, 4X sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer was added into the sample, which was then boiled in a 100°C waterbath for 10 min. Protein (50 μg) was loaded onto each lane, separated by 15% SDS-PAGE and transferred onto a polyvinylidene difluoride membrane. The membrane was blocked with 5% skimmed milk for 2 h and then probed with p-ERK1/2 (1:1,000; 9101; Cell Signaling, Beverly, MA, USA) or ERK1/2 (1:1,000; 9102; Cell Signaling, Beverly, MA, USA) at 4°C overnight. The detection was performed using horseradish peroxidase-conjugated goat anti-rabbit IgG and developed using 0.05% 3,3′-diaminobenzidine in PBS containing 0.01% H2O2. The bands on the membrane were scanned and analyzed by Eaglesight software (Stratagene, La Jolla, CA, USA). The proteins were visualized by an enhanced chemiluminescence system (Bioshine, Shanghai, China).

Statistical analysis

The data were expressed as the mean ± standard deviation. Significant differences between groups were determined by a one-way analysis of variance and the t-test. P<0.05 was used to indicate a statistically significant difference.

Results

Effects of AST on learning and memory impairment in I/R rats

To measure the correlation between the brain I/R injury and cognitive deficits and the protective effects of AST in rats, learning and memory was assessed by the MWM test. At each day of observation of the MWM test, the ischemic rats spent more time locating the submerged platform when compared with the sham rats. At days 4, 5 and 6, the AST (20 mg/kg)-treated ischemic rats showed a trend towards locating the platform in a shorter time relative to the ischemic group. The AST (40 mg/kg)-treated group exhibited a shortened latency at day 6, while AST (80 mg/kg) also had the same effect at days 5 and 6. At the last testing day (day 7), AST (20, 40, 80 mg/kg) markedly shortened the time it took to locate the hidden platform compared with the ischemic rats (P<0.05 or P<0.01) (Table I).

Table I

Effects of AST on the escape latency during the training session in the MWM test in I/R rats (mean ± standard deviation, n=8).

Table I

Effects of AST on the escape latency during the training session in the MWM test in I/R rats (mean ± standard deviation, n=8).

Latency, sec

GroupDose, mg/kg4 days5 days6 days7 days
Sham-70.92±17.3160.70±15.4247.55±11.9933.57±9.86
Model-94.19±18.47a85.29±15.02b79.84±18.40b67.81±15.60b
Gin4078.42±22.2173.88±15.2560.22±16.17c48.90±7.71d
AST2079.87±20.6170.48±19.5064.64±12.6251.85±9.04c
4078.01±22.4875.63±12.8061.34±15.73c49.05±6.73d
8075.59±20.8669.59±13.19c55.78±18.34c46.01±13.65d

a P<0.05 and

b P<0.01 vs. the sham group;

c P<0.05 and

d P<0.01 vs. the model group.

{ label (or @symbol) needed for fn[@id='tfn5-mmr-09-04-1319'] } ASTs, astragalosides; Gin, ginaton; I/R, ischemia/reperfusion; MWM, morris water maze.

The length of the path the rats swam to locate the platform was also recorded to assess the acquisition of the water-maze task. Compared with the sham group, the I/R group rats swam a longer distance to locate the platform (P<0.01). AST (40 mg/kg) shortened the distance at day 6, and AST (40 mg/kg) had the same action at days 5 and 6. On the last testing day, AST (20, 40, 80 mg/kg) markedly shortened the distance swam when compared with the I/R group (P<0.01) (Table II).

Table II

Effects of AST on the swim distance during the training session in the MWM in I/R rats (mean ± standard deviation, n=8).

Table II

Effects of AST on the swim distance during the training session in the MWM in I/R rats (mean ± standard deviation, n=8).

Distance, cm

GroupDose, mg/kg4 days5 days6 days7 days
Sham-1808.19±661.941502.32±503.841221.18±307.44833.62±173.04
Model- 2982.97±746.86a 2648.16±473.43a 2312.10±425.62a 1763.64±524.13a
Gin402312.00±589.51 2065.43±445.45b 1551.98±404.00c 1113.76±224.62c
AST202558.83±552.582254.27±565.87 1862.86±411.14b 1217.34±290.95b
402303.95±693.06 2060.13±451.50b 1528.46±431.47c 1083.47±260.98c
802258.92±640.11 1875.59±481.58c 1423.50±377.50c967.20±270.72c

a P<0.01 vs. the sham group;

b P<0.05 and

c P<0.01 vs. the model group.

{ label (or @symbol) needed for fn[@id='tfn9-mmr-09-04-1319'] } AST, astragalosides; I/R, ischemia/reperfusion; MWM, morris water maze; Gin, ginaton.

Effect of AST on neuronal degenerative changes and apoptosis in the hippocampus of I/R rats

To investigate the correlation between memory impairment and neuronal degeneration and apoptosis, the neuropathology and levels of apoptosis were measured (Fig. 1). The model group demonstrated neuron degeneration in the hippocampus (CA1), whereas no evident neuronal abnormalities were present in the control group. The neuronal cell bodies became small and deeply stained with dye. AST may improve the pathomorphological changes of the hippocampal neurons and reduce the neuronal chromatin, which is condensed.

Hippocampal neuronal apoptosis was explored further by staining with Hoechst 33258, which binds to chromatin and allows fluorescent visualization of normal and condensed chromatin. Morphologically, the cells undergoing apoptosis became small and deeply stained and cellular fragmentation into apoptotic bodies occured (Fig. 2A). Compared with the control group, the percentage of condensed cells in the hippocampus increased in the MCAO rats, whereas AST significantly decreased the percentage in the hippocampus (CA1) (Fig. 2B).

Effect of AST on the neurological function evaluation of MCAO rats

A neurological deficit score may indicate the neurological function impairment of rats following ischemia reperfusion injury. AST (40, 80 mg/kg) significantly reduced the neurological deficit score when compared with the I/R group, indicating that pretreatment with AST may improve the neurological disorder induced by cerebral I/R (Table III).

Table III

Effect of AST on the neurological function evaluation of rats following I/R injury (mean±standard deviation, n=8).

Table III

Effect of AST on the neurological function evaluation of rats following I/R injury (mean±standard deviation, n=8).

GroupDose, mg/kgNeurological deficit score

2 h22 h
Sham-0.00±0.000.00±0.00
Model-2.38±0.522.63±0.52
Gin402.25±0.711.88±0.64a
AST402.50±0.532.00±0.53a
802.13±0.641.88±0.35b

a P<0.01 vs. I/R group.

b P<0.01 vs. model group.

{ label (or @symbol) needed for fn[@id='tfn12-mmr-09-04-1319'] } AST, astragalosides; I/R, ischemia/reperfusion; Gin, ginaton.

Effects of AST on the activity of p-ERK, p-JNK and p-Akt in the brains of I/R rats

To further analyze the cell signaling pathways responsible for the AST neuroprotective effects, western blotting was performed with tissue samples obtained from the brain tissue of the ischemic rats. As shown in Fig. 3, the bands for p-ERK, p-JNK and p-Akt were observed in each group. The level of p-ERK, p-JNK and p-Akt was quantified by densitometry. There was increased phosphorylation of ERK and Akt, and decreased phosphorylation of JNK in the I/R group; pretreatment with AST (40 or 80 mg/kg) may activate ERK and Akt phosphorylation while depressing JNK phosphorylation further.

Discussion

The development of mazes to investigate spatial learning and memory has provided a method to determine the protective effects of drugs on the behavioral consequences and the neurological damage to the hippocampus and other areas involved in the neurotoxic effects of ischemia (12). The deficits on the learning and memory of rats following I/R injury was therefore measured by MWM in the present study. MCAO induced a failure in the spatial memory function of the rats when they were tested on days 4 to 7 following the surgery. This result demonstrated that AST shortened the latency and distance of swimming compared with the I/R group, which indicated that AST was able to diminish the abnormal behavioral performance following I/R. Gin is extracted from the leaves of Ginkgo biloba and is a famous Chinese traditional medicine used for treating cerebrovascular diseases and Alzheimer’s disease, therefore it was selected as a positive control. The data revealed that Gin may shorten the latency and distance of swimming, similar to the effects of AST.

The I/R injury induced neuronal apoptosis and learning and memory impairments, therefore, the protective effects of AST on neuronal apoptosis in the hippocampus were investigated further. Apoptosis is a subtype of cell death that is involved in diverse physiological and pathological processes (13). In the present study, a histological examination revealed that the neuronal cell bodies became short and deeply stained with dye following I/R injury, and nuclear staining with Hoechst 33258 displayed nuclear condensation and fragmentation in the cells undergoing apoptosis. AST may ameliorate these pathological changes and inhibit the apoptosis in the hippocampus in MCAO rats. This may be the protective mechanism of AST on I/R injury.

Our previous data demonstrated that AST may increase the expression of NGF and BDNF and the mRNA expression of TrkA and TrkB, while decreasing the p75 NTR mRNA level (7,8). Therefore we hypothesize that AST may produce a marked effect through growth factors and downstream signaling pathways. The ERK, JNK and Akt signaling pathways may regulate neuronal survival and apoptosis following ischemia, but the majority of studies agree that the levels of p-ERK, p-JNK and p-Akt decrease after 24 h or more following ischemia (14,15), therefore the level of p-ERK, p-JNK and p-Akt was detected 22 h after reperfusion in the present study. The p-ERK levels were enhanced following use of a variety of protective agents, such as BDNF and erythropoietin (1618). The phosphorylation of ERK is an essential component in inducing neuroprotection. The serine/threonine kinase, Akt, also known as protein kinase B, enhances survival with cerebral ischemia through a PI3-kinase-dependent signaling pathway. PI3K/Akt signaling is also important in neurogenesis. In addition, Akt is a critical mediator of cellular responses to growth factors, whereas JNK may be a key mediator for the transmission of apoptotic signals to mitochondrial apoptosis-related proteins (19,20). The JNK signaling pathway has been demonstrated to be activated following focal cerebral ischemia. Furthermore, ischemia-induced JNK activity may promote neuronal apoptosis (21). In the present study, the changes in ERK, JNK and Akt phosphorylation were measured in the rats treated with AST, and the results revealed that AST was able to increase ERK and Akt phosphorylation and decrease the expression of p-JNK following I/R.

In conclusion, the present study indicated that AST may attenuate learning and memory impairments in rats following ischemia-reperfusion, and that this may be associated with the regulation of ERK, JNK and Akt phosphorylation and their expression levels.

Acknowledgements

This study was supported by grants from The Nature Science Foundation of Anhui Province Education (grant nos. KJ2008B301 and KJ2009A81), Young Teachers in Colleges and Universities Provincial Research Projects of Anhui Province (grant no. 2008jq1059zd).

References

1 

Hattori K, Lee H, Hurn PD, Crain BJ, Traystman RJ and DeVries AC: Cognitive deficits after focal cerebral ischemia in mice. Stroke. 31:1939–1944. 2000. View Article : Google Scholar : PubMed/NCBI

2 

Bouët V, Freret T, Toutain J, Divoux D, Boulouard M and Schumann-Bard P: Sensorimotor and cognitive deficits after transient middle cerebral artery occlusion in the mouse. Exp Neurol. 203:555–567. 2007.PubMed/NCBI

3 

Shioda N, Han F, Morioka M and Fukunaga K: Bis(1-oxy-2-pyridinethiolato)oxovanadium(IV) enhances neurogenesis via phosphatidylinositol 3-kinase/Akt and extracellular signal regulated kinase activation in the hippocampal subgranular zone after mouse focal cerebral ischemia. Neuroscience. 155:876–887. 2008. View Article : Google Scholar

4 

Lee TH, Kato H, Chen ST, Kogure K and Itoyama Y: Expression of nerve growth factor and trkA after transient focal cerebral ischemia in rats. Stroke. 29:1687–1697. 1998. View Article : Google Scholar : PubMed/NCBI

5 

Irving EA and Bamford M: Role of mitogen- and stress-activated kinases in ischemic injury. J Cereb Blood Flow Metab. 22:631–647. 2002. View Article : Google Scholar : PubMed/NCBI

6 

Zhao H, Shimohata T, Wang JQ, Sun G, Schaal DW, Sapolsky RM and Steinberg GK: Akt contributes to neuroprotection by hypothermia against cerebral ischemia in rats. J Neurosci. 25:9794–9806. 2005. View Article : Google Scholar : PubMed/NCBI

7 

Yin YY, Li WP, Gong HL, Zhu FF, Li WZ and Wu GC: Protective effect of astragaloside on focal cerebral ischemia/reperfusion injury in rats. Am J Chin Med. 38:517–527. 2010. View Article : Google Scholar : PubMed/NCBI

8 

Yin YY, Li WP, Li WZ, Gong HL, Zhu FF and Wu GC: Effects of astragalosides on the expression of BDNF, TrkB and p75NTR mRNA against focal cerebral ischemia-reperfusion injury. Chinese Pharmacological Bulletin. 25:672–676. 2009.

9 

Li W, Li W, Yin Y, Gong H, Wu G and Zhu F: Protective effects of AST and ASI on memory impairment and its mechanism in senescent rats treated by GC. Zhongguo Zhong Yao Za Zhi. 34:199–203. 2009.(In Chinese).

10 

Longa EZ, Weinstein PR, Carlson S and Cummins R: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 20:84–91. 1989. View Article : Google Scholar : PubMed/NCBI

11 

Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL and Bartkowski H: Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 17:472–476. 1986. View Article : Google Scholar : PubMed/NCBI

12 

Wiard RP, Dickerson MC, Beek O, Norton R and Cooper BR: Neuroprotective properties of the novel antiepileptic lamotrigine in a gerbil model of global cerebral ischemia. Stroke. 26:466–472. 1995. View Article : Google Scholar : PubMed/NCBI

13 

Li WZ, Li WP, Zhang W, Yin YY, Sun XX, Zhou SS, Xu XQ and Tao CR: Protective effect of extract of Astragalus on learning and memory impairments and neurons’ apoptosis induced by glucocorticoids in 12-month-old male mice. Anat Rec (Hoboken). 294:1003–1014. 2011.PubMed/NCBI

14 

Kim SJ, Yoo KY, Jeong CW, Kim WM, Lee HK, Bae HB, Kwak SH, Li M and Lee J: Urinary trypsin inhibitors afford cardioprotective effects through activation of PI3K-Akt and ERK signal transduction and inhibition of p38 MAPK and JNK. Cardiology. 114:264–270. 2009. View Article : Google Scholar : PubMed/NCBI

15 

Wang PR, Wang JS, Zhang C, Song XF, Tian N and Kong LY: Huang-Lian-Jie-Du-Decotion induced protective autophagy against the injury of cerebral ischemia/reperfusion via MAPK-mTOR signaling pathway. J Ethnopharmacol. 149:270–280. 2013. View Article : Google Scholar : PubMed/NCBI

16 

Zhang F, Wang S, Signore AP and Chen J: Neuroprotective effects of leptin against ischemic injury induced by oxygen-glucose deprivation and transient cerebral ischemia. Stroke. 38:2329–2336. 2007. View Article : Google Scholar : PubMed/NCBI

17 

Kilic E, Kilic U, Soliz J, Bassetti CL, Gassmann M and Hermann DM: Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways. FASEB J. 19:2026–2028. 2005.PubMed/NCBI

18 

Lange-Asschenfeldt C, Raval AP, Dave KR, Mochly-Rosen D, Sick TJ and Pérez-Pinzón MA: Epsilon protein kinase C mediated ischemic tolerance requires activation of the extracellular regulated kinase pathway in the organotypic hippocampal slice. J Cereb Blood Flow Metab. 24:636–645. 2004. View Article : Google Scholar

19 

Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, Bar-Sagi D, Jones SN, Flavell RA and Davis RJ: Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science. 288:870–874. 2000. View Article : Google Scholar : PubMed/NCBI

20 

Lei K, Nimnual A, Zong WX, Kennedy NJ, Flavell RA, Thompson CB, Bar-Sagi D and Davis RJ: The Bax subfamily of Bcl2-related proteins is essential for apoptotic signal transduction by c-Jun NH(2)-terminal kinase. Mol Cell Biol. 22:4929–4942. 2002. View Article : Google Scholar : PubMed/NCBI

21 

Okuno S, Saito A, Hayashi T and Chan PH: The c-Jun N-terminal protein kinase signaling pathway mediates Bax activation and subsequent neuronal apoptosis through interaction with Bim after transient focal cerebral ischemia. J Neurosci. 24:7879–7887. 2004. View Article : Google Scholar

Related Articles

Journal Cover

2014-April
Volume 9 Issue 4

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wu YY, Wu WY, Gong HL, Li WZ and Yin YY: Astragalosides attenuate learning and memory impairment in rats following ischemia‑reperfusion injury. Mol Med Rep 9: 1319-1324, 2014
APA
Wu, Y., Wu, W., Gong, H., Li, W., & Yin, Y. (2014). Astragalosides attenuate learning and memory impairment in rats following ischemia‑reperfusion injury. Molecular Medicine Reports, 9, 1319-1324. https://doi.org/10.3892/mmr.2014.1969
MLA
Wu, Y., Wu, W., Gong, H., Li, W., Yin, Y."Astragalosides attenuate learning and memory impairment in rats following ischemia‑reperfusion injury". Molecular Medicine Reports 9.4 (2014): 1319-1324.
Chicago
Wu, Y., Wu, W., Gong, H., Li, W., Yin, Y."Astragalosides attenuate learning and memory impairment in rats following ischemia‑reperfusion injury". Molecular Medicine Reports 9, no. 4 (2014): 1319-1324. https://doi.org/10.3892/mmr.2014.1969